Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 208, Issue 1-2, 2003, Pages 67-70

  Wada, Manabu ^a   Ono, Seiitsu ^b   Kadoya, Toshihiko ^c   Kawanami, Toru ^a   Kurita, Keiji ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Galectin 1; Immunohistochemistry; Motor neuron; Skin; Spheroid

Indexed keywords

ANTIBODY; GALECTIN 1;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTONEURON; PATHOLOGY; PRIORITY JOURNAL; SKIN; SKIN BIOPSY;

EID: 0344255726     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00424-0     Document Type: Article

References (19)

1. Hirano A., Inoue K. Early pathological changes of amyotrophic lateral sclerosis: electron microscopic study of chromatolysis, spheroids and Bunina bodies. Neurol. Med. (Tokyo). 13:1980;148-160.
2. Kato T., Kurita K., Seino T., Kadoya T., Horie H., Wada M.et al. Galectin-1 is a component of neurofilamentous lesions in sporadic and familial amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 282:2001;166-172.
3. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124:1994;96-107. [Suppl.].
4. Ono S., Hu J., Imai T., Shimizu N., Tsumura M., Nakagawa H. Increased expression of insulin-like growth factor I in skin in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 69:2000;199-203.
5. Ono S., Imai T., Aso A., Yamano T., Shimizu N., Nagao K. Alteration of skin glycosaminoglycans in patients with ALS. Neurology. 51:1998;399-404.
6. Ono S., Imai T., Shimizu N., Nakagawa H., Hu J. Ciliary neurotrophic factor in skin biopsies of patients with amyotrophic lateral sclerosis. Lancet. 352:1998;958-959.
7. Horie H., Inagaki Y., Sohma Y., Nozawa R., Okawa K., Hasegawa M.et al. Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy. J. Neurosci. 19:1999;9964-9974.
8. Caron M., Bladier M., Joubert R. Soluble galactoside-binding vertebrate lectins: a protein family with common properties. Int. J. Biochem. 22:1990;1379-1385.
9. Drickamer K., Taylor M.E. Biology of animal lectins. Annu. Rev. Cell Biol. 9:1993;237-264.
10. Ono S., Toyokura Y., Mannen T., Ishibashi Y. Amyotrophic lateral sclerosis: histologic, histochemical, and ultrastructural abnormalities of skin. Neurology. 36:1986;948-956.
11. Ono S., Mechanic G.L., Yamauchi M. Amyotrophic lateral sclerosis: unusually low content of collagen in skin. J. Neurol. Sci. 100:1990;234-237.
12. Akimoto Y., Hirabayashi J., Kasai K.-I., Hirano H. Expression of the endogenous 14-kDa β-galactoside-binding lectin galectin in normal human skin. Cell Tissue Res. 280:1995;1-10.
13. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature. 378:1995;736-739.
14. Goldring K., Jones G.E., Sewry C.A., Watt D.J. The muscle-specific marker desmin is expressed in a proportion of human dermal fibroblasts after their exposure to galectin-1. Neuromuscul. Disord. 12:2002;183-186.
15. Goldring K., Jones G.E., Thiagarajah R., Watt D.J. The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vivo. J. Cell Sci. 115:2001;355-366.
16. Yamaoka K., Ohno S., Kawasaki H., Suzuki K. Overexpression of β-galactoside binding protein causes transformation of BALB3T3 fibroblast cells. Biochem. Biophys. Res. Commun. 179:1991;272-279.
17. Collad J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
18. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 2:1999;50-56.
19. Zhang B., Tu P., Abtahian F., Torjanowski J.Q., Lee V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 139:1997;1307-1315.